Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine and eCIMT for Severe Arm Paresis After Stroke
NCT01963832Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluoxetine in stroke (4 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Motor Activity Log Arm Use Scale at 90 days. Planned start Nov 2016; status: withdrawn.
02
Drugs
fluoxetine
03
Conditions
stroke
Beyond the preview
Go deeper on NCT01963832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963832.